These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

65 related articles for article (PubMed ID: 17709348)

  • 1. Role of medications in symptomatic hyperkalemia.
    Kurisu S; Inoue I; Kawagoe T; Ishihara M; Shimatani Y; Nakama Y; Maruhashi T; Kagawa E; Dai K; Aokage T
    QJM; 2007 Sep; 100(9):591-3. PubMed ID: 17709348
    [No Abstract]   [Full Text] [Related]  

  • 2. Study warns of danger of combining spironolactone and ACE inhibitors in heart patients.
    Gottlieb S
    BMJ; 2004 Aug; 329(7463):420. PubMed ID: 15321896
    [No Abstract]   [Full Text] [Related]  

  • 3. [Old and new drugs to block aldosterone and ameliorate cardiovascular disease].
    Fiebeler A; Luft FC
    Dtsch Med Wochenschr; 2004 Nov; 129(46):2491-6. PubMed ID: 15536584
    [No Abstract]   [Full Text] [Related]  

  • 4. Hyperkalaemia: again.
    Gross P; Pistrosch F
    Nephrol Dial Transplant; 2004 Sep; 19(9):2163-6. PubMed ID: 15299094
    [No Abstract]   [Full Text] [Related]  

  • 5. [Current use of acetazolamide as a diuretic: usefulness in refractory edema and in aldosterone-antagonist-related hyperkalemia].
    Caramelo C; Albalate M; Tejedor A; Alcázar R; Baldoví S; García Pérez A; Marín M
    Nefrologia; 2008; 28(2):234-8. PubMed ID: 18454727
    [No Abstract]   [Full Text] [Related]  

  • 6. [Late drug-induced hyperkalemia in a patient with congestive heart failure].
    Konopa J; Bułło B; Rutkowski B
    Przegl Lek; 2005; 62(7):732-3. PubMed ID: 16463712
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Ineffective atrial pacing and cardiac arrest in a 80-year old woman with hyperkalemia].
    Lelakowski J; Czunko A; Majewski J; Pasowicz M; Małecka B; Bednarek J
    Pol Merkur Lekarski; 2005 May; 18(107):566-7. PubMed ID: 16161957
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Captopril induced hyperkalemia in a child.
    Sunder RA; Rakesh G; Rudingwa P; Chanderlekha
    Paediatr Anaesth; 2009 Apr; 19(4):404-5. PubMed ID: 19335351
    [No Abstract]   [Full Text] [Related]  

  • 9. [Let's read the domestic literature. ACE-inhibitors and spironolactone-induced hyperkalemia].
    Radó J
    Orv Hetil; 2002 Aug; 143(31):1868; author reply 1868. PubMed ID: 12187583
    [No Abstract]   [Full Text] [Related]  

  • 10. Hyperkalemia after the publication of RALES.
    Witham MD; Gillespie ND; Struthers AD
    N Engl J Med; 2004 Dec; 351(23):2448-50; author reply 2448-50. PubMed ID: 15580679
    [No Abstract]   [Full Text] [Related]  

  • 11. Hyperkalemia after the publication of RALES.
    Goldfarb DS
    N Engl J Med; 2004 Dec; 351(23):2448-50; author reply 2448-50. PubMed ID: 15575065
    [No Abstract]   [Full Text] [Related]  

  • 12. Hyperkalemia after the publication of RALES.
    Newsome BB; Warnock DG
    N Engl J Med; 2004 Dec; 351(23):2448-50; author reply 2448-50. PubMed ID: 15580678
    [No Abstract]   [Full Text] [Related]  

  • 13. [Life threatening drug-induced hyperkaliemia--case report].
    Konopa J; Bullo B; Rutkowski B
    Pol Arch Med Wewn; 2006 Mar; 115(3):238-42. PubMed ID: 18468430
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Hyperkalemia after the publication of RALES.
    Cavallari L; Vaitkus P; Groo V
    N Engl J Med; 2004 Dec; 351(23):2448-50; author reply 2448-50. PubMed ID: 15580677
    [No Abstract]   [Full Text] [Related]  

  • 15. Adverse effects of combination angiotensin II receptor blockers plus angiotensin-converting enzyme inhibitors for left ventricular dysfunction: a quantitative review of data from randomized clinical trials.
    Phillips CO; Kashani A; Ko DK; Francis G; Krumholz HM
    Arch Intern Med; 2007 Oct; 167(18):1930-6. PubMed ID: 17923591
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Severe hyperkalaemia with prescription of potassium-retaining agents in an elderly patient.
    Martin J; Mourton S; Nicholls G
    N Z Med J; 2003 Aug; 116(1179):U542. PubMed ID: 14513088
    [No Abstract]   [Full Text] [Related]  

  • 17. Hyperkalemia risk and treatment of heart failure.
    Segura J; Ruilope LM
    Heart Fail Clin; 2008 Oct; 4(4):455-64. PubMed ID: 18760757
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Spironolactone + ace inhibitor or sartan: risk of hyperkalaemia.
    Prescrire Int; 2004 Apr; 13(70):58. PubMed ID: 15148978
    [No Abstract]   [Full Text] [Related]  

  • 19. Combining neuroendocrine inhibitors in heart failure: reflections on safety and efficacy.
    Jneid H; Moukarbel GV; Dawson B; Hajjar RJ; Francis GS
    Am J Med; 2007 Dec; 120(12):1090.e1-8. PubMed ID: 18060931
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The role of aldosterone blockade in end-stage renal disease.
    Pitt B; Saran R
    Cardiology; 2009; 114(1):30-1. PubMed ID: 19342856
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 4.